Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMe Augmentation of SSRIs for TRD
NCT00093847Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2004
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing SAMe + SSRI with Placebo + SSRI (2 arms). Primary endpoint: Hamilton Depression Rating Scale Remission Rates at 6 weeks. Started May 2004; status: completed.
02
Drugs
S-adenosylmethionine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00093847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093847.